The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Interventions for valvular disease and heart failure

Will the Evolut Low Risk trial change my practice?

EuroIntervention 2019;15:e1072-e1076. DOI: 10.4244/EIJ-D-19-00587

1. Department of Cardiology, Bon Secours Hospital, Cork, Ireland; 2. Department of Cardiovascular Surgery, Houston Methodist Hospital, Houston, TX, USA; 3. Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 4. Department of Cardiac Surgery, University Heart Centre Hamburg, Hamburg, Germany; 5. Applied Health Research Centre (AHRC), Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Department of Medicine and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada; 6. Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland

The “Will this trial change my practice?” sessions at PCR

The aim of the article is to capture this session at EuroPCR 2019, communicate the analysis of the trialists, and report the views expressed in the interactive discussion.

Introduction to the session

The session took the following format: the Chairperson was S. Windecker, with H. Treede as Co-chairperson and C. O’Sullivan as Participant. “The Introduction - the trial headlines” was presented by S. Windecker. A “How should I treat?” case was presented by M. Reardon; “What was known ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Will the PARTNER 3 Low Risk Trial change my practice?